+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Systemic treatment for hepatocellular carcinoma: Still unmet expectations



Systemic treatment for hepatocellular carcinoma: Still unmet expectations



World Journal of Hepatology 9(2): 80-90



Many patients with hepatocellular carcinoma (HCC) are diagnosed in an advanced stage, so they cannot be offered the option of curative treatments. The results of systemic chemotherapy are unsatisfactory and this has led to molecular targeted approaches. HCC develops in chronically damaged tissue due to cirrhosis in most patients. Several different cell types and molecules constitute a unique microenvironment in the liver, which has significant implications in tumor development and invasion. This, together with genome instability, contributes to a significant heterogeneity which is further enhanced by the molecular differences of the underlying causes. New classifications based on genetic characteristics of the tissue microenvironment have been proposed and key carcinogenic signaling pathways have been described. Tumor and adjacent tissue profiling seem biologically promising, but have not yet been translated into clinical settings. The encouraging first results with molecular - genetic signatures should be validated and clinically applicable. A more personalized approach to modern management of HCC is urgently needed.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 060311941

Download citation: RISBibTeXText

PMID: 28144389

DOI: 10.4254/wjh.v9.i2.80


Related references

Change of Uncertainty in Illness and Unmet Care Needs in Patients With Recurrent Hepatocellular Carcinoma During Active Treatment. Cancer Nursing 41(4): 279-289, 2017

Hepatocellular carcinoma: Where there is unmet need. Molecular Oncology 9(8): 1501-1509, 2015

Fine-needle aspiration biopsy of hepatocellular carcinoma and related hepatocellular nodular lesions in cirrhosis: controversies, challenges, and expectations. Pathology Research International 2011: 587936, 2011

Systemic treatment for hepatocellular carcinoma. Chronic Diseases and Translational Medicine 4(3): 148-155, 2018

Systemic treatment of hepatocellular carcinoma. Digestive Diseases 19(4): 311-323, 2001

Systemic treatment for hepatocellular carcinoma. Zentralblatt für Chirurgie 128(11): 906-910, 2003

Systemic treatment of hepatocellular carcinoma. European Journal of Gastroenterology and Hepatology 16(3): 275-281, 2004

Systemic treatment of hepatocellular carcinoma: dawn of a new era?. Annals of Surgical Oncology 17(5): 1247-1256, 2010

Systemic treatment in hepatocellular carcinoma; 'A small step for man...'. Netherlands Journal of Medicine 67(3): 86-90, 2009

Systemic treatment options of primary hepatocellular carcinoma. Magyar Onkologia 62(1): 53-61, 2018

Review article: systemic treatment of hepatocellular carcinoma. Alimentary Pharmacology and Therapeutics 48(6): 598-609, 2018

Systemic Treatment of Advanced Hepatocellular Carcinoma in Older Adults. Journal of Nature and Science 4(8):, 2018

Systemic treatment of hepatocellular carcinoma: why so many failures in the development of new drugs?. Expert Review of Anticancer Therapy 16(10): 1053-1062, 2016

Systemic treatment of advanced hepatocellular carcinoma: from disillusions to new horizons. European Journal of Cancer 51(3): 327-339, 2015

Systemic treatment of hepatocellular carcinoma: Past, present and future. World Journal of Hepatology 9(18): 797-807, 2017